
Musculoskeletal Disorders Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
Description
Musculoskeletal Disorders Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global musculoskeletal disorders drugs market is expected to grow at a CAGR of around 6.5% during 2025-2034. This report on global musculoskeletal disorders drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global musculoskeletal disorders drugs market by segmenting the market based on type, route of administration, distribution channel and region. Also, detailed profiles of companies operating in the musculoskeletal disorder’s drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Increasing Incidences and Prevalence of Musculoskeletal Disorders
Market Challenges
• Low Access to Treatment
Historical & Forecast Period
Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034
Market by Type
• Analgesics
• Corticosteroids
• DMARDs
• Other Types
Market by Route of Administration
• Oral
• Parenteral
Market by Distribution Channel
• Hospital Pharmacies
• Online Providers
• Drug Stores and Retail Pharmacies
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
Table of Contents
122 Pages
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Musculoskeletal Disorders Drugs Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. Global Musculoskeletal Disorders Drugs Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Type
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 4.5. Impact of Russia-Ukraine War
- 5. Global Musculoskeletal Disorders Drugs Market by Type
- 5.1. Introduction
- 5.2. Analgesics
- 5.3. Corticosteroids
- 5.4. DMARDs
- 5.5. Other Types
- 6. Global Musculoskeletal Disorders Drugs Market by Route of Administration
- 6.1. Introduction
- 6.2. Oral
- 6.3. Parenteral
- 7. Global Musculoskeletal Disorders Drugs Market by Distribution Channel
- 7.1. Introduction
- 7.2. Hospital Pharmacies
- 7.3. Online Providers
- 7.4. Drug Stores and Retail Pharmacies
- 8. Global Musculoskeletal Disorders Drugs Market by Region
- 8.1. Introduction
- 8.2. Europe
- 8.2.1. Germany
- 8.2.2. United Kingdom
- 8.2.3. France
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Russia
- 8.2.7. Netherlands
- 8.2.8. Rest of the Europe
- 8.3. North America
- 8.3.1. United States
- 8.3.2. Canada
- 8.4. Asia Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. South Korea
- 8.4.5. Australia
- 8.4.6. Indonesia
- 8.4.7. Rest of the Asia Pacific
- 8.5. Latin America
- 8.5.1. Mexico
- 8.5.2. Brazil
- 8.5.3. Argentina
- 8.5.4. Rest of Latin America
- 8.6. Middle East & Africa
- 8.6.1. Saudi Arabia
- 8.6.2. Turkey
- 8.6.3. Iran
- 8.6.4. United Arab Emirates
- 8.6.5. Rest of Middle East & Africa
- 9. SWOT Analysis
- 10. Porter’s Five Forces
- 11. Market Value Chain Analysis
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Company Profiles
- 12.2.1. AbbVie Inc.
- 12.2.2. Amgen Inc.
- 12.2.3. AstraZeneca plc
- 12.2.4. Bristol-Myers Squibb Company
- 12.2.5. Eli Lilly and Company
- 12.2.6. GlaxoSmithKline plc
- 12.2.7. Johnson & Johnson
- 12.2.8. Merck & Co., Inc.
- 12.2.9. Novartis AG
- 12.2.10. Pfizer Inc.
- 12.2.11. Roche Holding AG
- 12.2.12. Sanofi S.A.
- List of Figures
- Figure 1: Global Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 2: Global Musculoskeletal Disorders Drugs Market by Type, 2024
- Figure 3: Global Musculoskeletal Disorders Drugs Market by Route of Administration, 2024
- Figure 4: Global Musculoskeletal Disorders Drugs Market by Distribution Channel, 2024
- Figure 5: Global Musculoskeletal Disorders Drugs Market by Region, 2024
- Figure 6: Global Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 7: Global Musculoskeletal Disorders Drugs Market by Type (in %), 2024 & 2034
- Figure 8: Global Analgesics Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 9: Global Analgesics Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 10: Global Corticosteroids Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 11: Global Corticosteroids Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 12: Global DMARDs Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 13: Global DMARDs Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 14: Global Other Types Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 15: Global Other Types Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 16: Global Musculoskeletal Disorders Drugs Market by Route of Administration (in %), 2024 & 2034
- Figure 17: Global Oral Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 18: Global Oral Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 19: Global Parenteral Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 20: Global Parenteral Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 21: Global Musculoskeletal Disorders Drugs Market by Distribution Channel (in %), 2024 & 2034
- Figure 22: Global Hospital Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 23: Global Hospital Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 24: Global Online Providers Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 25: Global Online Providers Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 26: Global Drug Stores and Retail Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 27: Global Drug Stores and Retail Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 28: Global Musculoskeletal Disorders Drugs Market by Region (in %), 2024 & 2034
- Figure 29: Europe Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 30: Europe Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 31: Europe Musculoskeletal Disorders Drugs Market by Country (in %), 2024 & 2034
- Figure 32: Germany Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 33: United Kingdom Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 34: France Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 35: Italy Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 36: Spain Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 37: Russia Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 38: Netherlands Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 39: North America Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 40: North America Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 41: North America Musculoskeletal Disorders Drugs Market by Country (in %), 2024 & 2034
- Figure 42: United States Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 43: Canada Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 44: Asia Pacific Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 45: Asia Pacific Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 46: Asia Pacific Musculoskeletal Disorders Drugs Market by Country (in %), 2024 & 2034
- Figure 47: China Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 48: Japan Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 49: India Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 50: South Korea Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 51: Australia Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 52: Indonesia Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 53: Latin America Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 54: Latin America Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 55: Latin America Musculoskeletal Disorders Drugs Market by Country (in %), 2024 & 2034
- Figure 56: Mexico Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 57: Brazil Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 58: Argentina Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 59: Middle East & Africa Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2024
- Figure 60: Middle East & Africa Musculoskeletal Disorders Drugs Market (in US$ Million), 2025-2034
- Figure 61: Middle East & Africa Musculoskeletal Disorders Drugs Market by Country (in %), 2024 & 2034
- Figure 62: Saudi Arabia Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 63: Turkey Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 64: Iran Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 65: UAE Musculoskeletal Disorders Drugs Market (in US$ Million), 2020-2034
- Figure 66: Market Value Chain
- List of Tables
- Table 1: Global Musculoskeletal Disorders Drugs Market Portraiture
- Table 2: Global Musculoskeletal Disorders Drugs Market by Type (in US$ Million), 2024 & 2034
- Table 3: Global Musculoskeletal Disorders Drugs Market by Route of Administration (in US$ Million), 2024 & 2034
- Table 4: Global Musculoskeletal Disorders Drugs Market by Distribution Channel (in US$ Million), 2024 & 2034
- Table 5: Global Musculoskeletal Disorders Drugs Market by Region (in US$ Million), 2024 & 2034
- Table 6: Europe Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2024 & 2034
- Table 7: North America Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2024 & 2034
- Table 8: Asia Pacific Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2024 & 2034
- Table 9: Latin America Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2024 & 2034
- Table 10: Middle East & Africa Musculoskeletal Disorders Drugs Market by Country (in US$ Million),
- 2024 & 2034
- Table 11: List of Key Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.